Degradation of Cry1Ab protein from genetically modified maize (MON810) in relation to total dietary feed proteins in dairy cow digestion
- 1.5k Downloads
To investigate the relative degradation and fragmentation pattern of the recombinant Cry1Ab protein from genetically modified (GM) maize MON810 throughout the gastrointestinal tract (GIT) of dairy cows, a 25 months GM maize feeding study was conducted on 36 lactating Bavarian Fleckvieh cows allocated into two groups (18 cows per group) fed diets containing either GM maize MON810 or nearly isogenic non-GM maize as the respective diet components. All cows were fed a partial total mixed ration (pTMR). During the feeding trial, 8 feed (4 transgenic (T) and 4 non-transgenic (NT) pTMR) and 42 feces (26 T and 18 NT) samples from the subset of cows fed T and NT diets, and at the end of the feeding trial, digesta contents of rumen, abomasum, small intestine, large intestine and cecum were collected after the slaughter of six cows of each feeding group. Samples were analyzed for Cry1Ab protein and total protein using Cry1Ab specific ELISA and bicinchoninic acid assay, respectively. Immunoblot analyses were performed to evaluate the integrity of Cry1Ab protein in feed, digesta and feces samples. A decrease to 44% in Cry1Ab protein concentration from T pTMR to the voided feces (9.40 versus 4.18 μg/g of total proteins) was recorded. Concentrations of Cry1Ab protein in GIT digesta of cows fed T diets varied between the lowest 0.38 μg/g of total proteins in abomasum to the highest 3.84 μg/g of total proteins in rumen. Immunoblot analysis revealed the extensive degradation of recombinant Cry1Ab protein into a smaller fragment of around 34 kDa in GIT. The results of the present study indicate that the recombinant Cry1Ab protein from MON810 is increasingly degraded into a small fragment during dairy cow digestion.
KeywordsCry1Ab protein Dairy cow Genetically modified maize MON810 Digesta
Genetically modified (GM) maize MON810, expressing the insecticidal Cry1Ab protein, has been approved as an animal feed in several countries worldwide. Already many studies on GM feeds have been documented regarding animal performance and health, as well as resultant food safety [reviewed by (Flachowsky et al. 2005; Report of the EFSA GMO panel working group on Animal feeding trials 2008)]. The previous studies (Chowdhury et al. 2003; Einspanier et al. 2004; Lutz et al. 2005) on the digestive fate of Cry1Ab protein from GM maize (events: Bt11 and Bt176) in ruminant gastrointestinal tract (GIT) revealed that the recombinant protein is degraded during digestion. However, there is no information available on the in vivo digestive fate of transgenic protein from MON810 in relation to other dietary feed proteins in ruminants.
In ruminants, a very special way of digestion exists for the breakdown of ingested feed material in the GIT. Unlike other mammals, ruminants have a four-chambered (rumen, reticulum, omasum and abomasum) stomach that is specially designed for the fermentation of dietary carbohydrates and proteins. The digestion process begins in rumen, using the microorganisms to breakdown the complex feed particles into simple sugar and volatile fatty acids. The fermented digesta from rumen passes in small amounts into the next chamber reticulum. From the reticulum the small packets of ingested food passes back into the mouth for chewing. The re-chewed food is then swallowed and passed into the omasum. The food in omasum is broken down into even smaller pieces by powerful muscular movements. After spending some time in the omasum, the food passes to the abomasum. In the abomasum, food is broken down by the digestive enzymes, particularly by the lysozymes. The digested food then passes into the small intestine, large intestine and finally undigested feed material is voided as feces. In intestine water from digesta is removed and nutrients are absorbed into blood streams.
In general, dietary proteins are broken down to decreasingly smaller fragments under the influence of a sequence of processes that occur in different segments of the GIT of ruminants. These processes include fermentation of dietary components by microbes during incubation in the reticulo-rumen, acid hydrolysis and degradation by enzymes of the host animal in the abomasum and small intestine, and secondary fermentation in the cecum and large intestine. Most of the ingested feed proteins are degraded by 40 to 80% of their initial amounts in the rumen and utilized by rumen microbes for the synthesis of microbial protein [as reviewed by (Chalupa 1975)]. However, maize proteins are relatively resistant to the ruminal degradation (Romagnolo et al. 1994). Also the site of digestion affects the nature of absorbed end-products and the extent of nutrient losses occurring during digestion. Thus, the objective of the present study was to determine stability or degradation of the Cry1Ab protein relative to total dietary proteins in feed, GIT digesta and feces of dairy cows.
Materials and methods
Ingredients and composition of the partial total mixed ration
Ratio (DM basis) (%)
To evaluate the digestive fate of recombinant Cry1Ab protein during the feeding trial, four samples of each diet (transgenic and non-transgenic maize kernel, cobs, silage, and pTMR) and forty-two feces samples (26 transgenic and 18 non-transgenic) were collected from the subset of cows. To determine the amount and fragmentation pattern of Cry1Ab protein in the GIT digesta, contents of rumen, abomasum, small intestine, large intestine and cecum were collected after the slaughter of six cows of each feeding group at the end of the feeding trial. All samples were stored at −80°C until analyzed for total protein and Cry1Ab protein.
All feed samples were finely ground in liquid nitrogen using mortar and pestle. Total proteins were extracted from the pulverized feed (100 mg), feces (100 mg) and GIT digesta (200 mg) samples after the homogenization with 1 ml ice-cold extraction buffer (PBST; 8 mM sodium phosphate, 137 mM NaCl, 2.7 mM KCl, 1.5 mM potassium phosphate, 0.1% Tween 20 pH 7.4; containing protease inhibitors) using 300 mg matrix green ceramic beads in a Fastprep homogenization machine. The supernatants were collected in 1.5 ml microcentrifuge tubes after centrifugation at 15,000×g at 4°C for 15 min. A clear extract was collected after re-centrifugation at 15,000×g at 4°C for 10 min and stored at −20°C until used for total protein and Cry1Ab protein quantification.
Total protein concentration in each extract was measured by bicinchoninic acid (BCA) assay (Smith et al. 1985) using BSA as protein standard. For determination of the Cry1Ab protein concentration, a previously developed sandwich ELISA (Paul et al. 2008) was used under slight modifications and matrix specific assay validations (Guertler et al. 2009a, b). Briefly, an assay was performed on Cry1Ab protein affinity purified specific antibody coated 96-well microtiter plates by incubating 50 μl of sample extract or Cry1Ab protein standards (HPLC-purified trypsin-activated Cry1Ab protein calibrator concentrations ranging from 2 to 1,000 pg per 50 μl extraction buffer) along with 100 μl assay buffer (PBST containing 0.1% BSA). After overnight incubation at 6 to 8°C, plates were washed six-times with 300 μl PBST per well. The amount of antibody captured Cry1Ab protein from samples/standards was measured by applying a biotin labeled Cry1Ab specific antibody, streptavidin-peroxidase enzyme conjugate and 3,3′,5,5′-tetramethylbenzidine (TMB) substrate reaction. Cry1Ab protein concentrations in unknown samples were interpreted from the Cry1Ab protein calibration curve generated using online software Magellan 6 (Tecan, Austria). The concentrations were finally presented as μg Cry1Ab protein per g total protein and ng Cry1Ab protein per g wet sample.
To monitor the fragmentation of Cry1Ab protein from MON810 in transgenic feed, GIT digesta and feces immunoblot analyses were performed. Total protein (60 μg total protein or 100 pg Cry1Ab protein extracts from T feed and feces or respective equivalent amount of total protein from NT feed and feces) of transgenic and non-transgenic feed, GIT digesta and feces were resolved on 12% SDS–PAGE and transferred to nitrocellulose membranes (Protran AB 85, Whatman, Dassel, Germany). Membranes with blotted protein bands were incubated with affinity purified anti-Cry1Ab protein (rabbit pAb, 0.1 μg/ml) (Paul et al. 2008) and HRP-labeled polyclonal goat anti-rabbit secondary (1:10,000) antibody (Santa Cruz biotechnology, Germany). Antibody binding was visualized by chemiluminescence (Supersignal west pico system, Pierces, USA). In immunoblot analysis, a positive control containing HPLC purified trypsin activated Cry1Ab protein (65 kDa) was used to confirm and verify the positive presence of Cry1Ab protein. Student’s t-test was used to compare the means of Cry1Ab protein concentrations in transgenic feed and feces, and total proteins in GIT digesta of cows fed transgenic and non-transgenic diets. A P-value below 0.05 was considered significant.
Results and discussion
In conclusion, the results of the present study indicate that Cry1Ab protein from MON810 is increasingly degraded during dairy cow digestion via small fragments of 42 kDa, 34 kDa and 17 kDa. In comparison with total protein in feed, the relative amount of Cry1Ab protein in feces is markedly reduced indicating that Cry1Ab protein is not more stable than other proteins in the feed.
This study was funded by the Bavarian State Ministry of Nutrition, Agriculture and Forestry. The authors gratefully acknowledge the assistance from staff and colleagues at TUM and Bavarian State Research Center.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
- Chowdhury EH, Shimada N, Murata H, Mikami O, Sultana P, Miyazaki S, Yoshioka M, Yamanaka N, Hirai N, Nakajima Y (2003) Detection of Cry1Ab protein in the gastrointestinal contents but not visceral organs of genetically modified Bt11fed calves. Vet Hum Toxicol 43:71–75Google Scholar
- Guertler P, Paul V, Steinke K, Preissinger W, Wiedemann S, Albrecht C, Spiekers H, Schwarz F, Meyer H (2009b) Investigations on the potential transfer of recombinant DNA and Cry1Ab protein from feed into milk, blood, feces and urine of cows fed genetically modified maize. Proc Soc Nutr Physiol 18:111 (Abstract)Google Scholar
- Steinke K, Paul V, Guertler P, Preissinger W, Wiedemann S, Albrecht C, Spiekers H, Meyer H, Schwarz F (2009) Effects of long-term feeding of genetically modified maize (Bt-maize; MON810) to dairy cows on performance and metabolic parameters. Proc Soc Nutr Physiol 18:110 (Abstract)Google Scholar